DNA PLOIDY & S PHASE (LEUKEMIA) BY FLOW CYTOMETRY / HEPARIN BLOOD

image not found

NABL Cap Accredited 
The DNA Ploidy & S Phase (Leukemia) by Flow Cytometry / Heparin Blood test assesses the DNA content and cell cycle distribution of leukemia cells to evaluate tumor proliferation and prognosis. Metropolis Healthcare uses advanced flow cytometry techniques for precise measurement of DNA ploidy and S-phase fraction. This test aids clinicians in risk stratification, treatment planning, and monitoring response in patients with leukemia. A heparinized blood sample ensures optimal preservation of cellular DNA for accurate analysis.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,200.00

Sample Type: HEPARIN BLOOD

Fasting Not Required


Notes: D8423

Frequently Asked Questions (FAQ's):

What does the DNA Ploidy & S Phase test include?
This test measures DNA content (ploidy) and the proportion of cells in S-phase to assess leukemia cell proliferation and prognosis.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses validated flow cytometry protocols with strict quality control to accurately analyze DNA ploidy and S-phase fraction in leukemia cells.

Who should take this test?
Patients diagnosed with leukemia or undergoing evaluation for hematologic malignancies may be advised to take this test.

What sample type is required?
A heparinized blood sample is required for precise measurement of DNA content and cell cycle analysis.

Why is DNA ploidy and S-phase analysis important?
Assessing DNA ploidy and S-phase fraction helps predict disease aggressiveness, guide therapy, and monitor treatment response.

How reliable are results from Metropolis Healthcare?
Metropolis Healthcare follows stringent quality control, validated flow cytometry protocols, and expert interpretation to ensure accurate and reproducible results.

Is any preparation needed before the test?
No special preparation or fasting is typically required; patients should follow any instructions provided by their physician.

How soon are results available?
Turnaround time may vary, but Metropolis Healthcare typically provides timely reports to support clinical evaluation and leukemia management.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab